Skip to main content Skip to section navigation Skip to footer

Mydecine Innovations Group Inc.

  • Home
  • About
    • Overview
    • Company History
    • Acquisitions
    • Partnerships
    • Leadership Team
    • Board of Directors
    • Research & Development Team
    • Medical, Scientific and Technology Advisory Board
  • Our Approach
    • IP & Drug Development
    • Clinical Trials
    • Technology
  • Drug Supply
    • Investigational Drug Supply
    • Special Access Program
  • News & Media
    • Blog
    • Press Releases
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • Governance
    • FAQs
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Blog
  • Press Releases
  • In The News
Jun 03, 2021 7:30am EDT

Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th

May 25, 2021 7:30am EDT

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

May 19, 2021 7:30am EDT

Mydecine Provides Update on Spin-Out of U.S. Cannabis Assets

May 18, 2021 7:30am EDT

Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update

May 10, 2021 7:30am EDT

Mydecine to Participate in the Benzinga Global Small Cap Conference on May 13th

May 05, 2021 7:30am EDT

Mydecine Announces Partnership with LeadGen Labs

May 03, 2021 7:30am EDT

Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Apr 26, 2021 7:30am EDT

Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Apr 13, 2021 7:30am EDT

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Apr 07, 2021 7:30am EDT

Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

rss_feed News RSS
  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward

Sign up for our Newsletter!

twitter Linkedin Instagram
©2022 Mydecine Innovations Group Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap